CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-20 | SCHIMMEL PAUL Director | Purchase | +250,000 | $8.00 | $2.0M | 252,890 |
| 2021-09-20 | SCHIMMEL PAUL Director | Gift | −250,000 | 2,890 | ||
| 2021-09-20 | SCHIMMEL PAUL Director | Gift | +250,000 | 679,143 | ||
| 2021-05-21 | DENYES NANCY General Counsel | Grant or award · Employee Stock Option (Right to buy) | +59,000 | 59,000 | ||
| 2021-05-21 | CLARKE JOHN K Director | Sale | −2,500 | $4.34 | $11K | 108,083 |
| 2021-05-21 | Broadfoot Jill Marie Chief Financial Officer | Grant or award · Employee Stock Option (Right to buy) | +54,000 | 54,000 | ||
| 2021-05-21 | Shukla Sanjay President and CEO | Grant or award · Employee Stock Option (Right to buy) | +207,000 | 207,000 | ||
| 2021-05-21 | Zaknoen Sara Director | Grant or award · Stock Option (right to buy) | +2,285 | 2,285 | ||
| 2021-05-18 | SCHIMMEL PAUL Director | Purchase | +50,000 | $3.98 | $199K | 113,023 |
| 2021-05-18 | Shukla Sanjay President and CEO | Purchase | +10,000 | $4.01 | $40K | 18,298 |
| 2021-04-28 | SCHIMMEL PAUL Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2021-04-28 | Lucas Svetlana Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2021-04-28 | Gross Jane A Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2021-04-28 | COUGHLIN TIMOTHY Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2021-04-28 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +1,428 | 1,428 | ||
| 2021-02-09 | Broadfoot Jill Marie Chief Financial Officer | Sale | −390 | $7.66 | $3K | 9,833 |
| 2021-02-09 | Shukla Sanjay President and CEO | Sale | −778 | $7.66 | $6K | 8,298 |
| 2021-02-06 | Broadfoot Jill Marie Chief Financial Officer | Option exercise | +892 | 10,223 | ||
| 2021-02-06 | Broadfoot Jill Marie Chief Financial Officer | Option exercise · Restricted Stock Unit | −892 | 0 | ||
| 2021-02-06 | Shukla Sanjay President and CEO | Option exercise | +1,785 | 9,076 |
Page 7 of 15 · 284 trades